What You Need to Know About Influenza Pathways &...
Host: John Russell, MD Guest: Michael G. Ison, MD, MS What’s the difference between a neuraminidase inhibitor and an endonuclease inhibitor? That’s what this activity will explore, in addition to how this new endonuclease inhibitor works, if it’s for everyone, and which biologic pathways and related MOAs for antiviral agents are effective against influenza A and B. Since the launch of the activity, the US FDA has approved a new indication for baloxavir marboxil to include the
en